FDA Drug Application (021271) for IPRIVASK by VALEANT PHARMS NORTH

Back to FDA Applications sponsored by VALEANT PHARMS NORTH

Application Number021271
Product Number001
FormINJECTABLE;SUBCUTANEOUS
Dosage15MG/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameIPRIVASK
Active IngredientDESIRUDIN RECOMBINANT



Back to FDA Applications sponsored by VALEANT PHARMS NORTH